Docmode Health Technologies share price & results
- Mar 2026
- Mar 2026
Mumbai-based healthcare-technology company running an integrated ecosystem of medical education, HCP market/clinical research, practice-enhancement tools and CRO/CRAMS contract-research services for healthcare professionals and pharma compa
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 7.7 | −64.1% YoY | Quarterly, as filed | Quarter to Mar 2026 | Revenue from operations as filed. |
| Operating margin | -15.0 | −12.3 pts YoY | Operating profit / revenue | Quarter to Mar 2026 | For the quarter; a change is in percentage points. |
| Net profit | -0.07 | Quarterly, as filed | Quarter to Mar 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. | |
| Return on equity | +20.1 pts | Trailing twelve months | TTM · period unavailable | Not in the analysed materials. No older figure is substituted. | |
| Free cash flow margin | 9.53 | +2.3 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | −43.6 pts | Trailing twelve months | TTM · period unavailable | Not in the analysed materials. No older figure is substituted. |
Price
Performance −81.2% 1Y
1Y: ₹117.3 on 23 Oct 2025 → ₹22.05. High ₹122.75 (31 Oct 2025), low ₹22 (22 Oct 2026).
- Previous close
- ₹22
- Market cap
- ₹7 Cr
- 52-week range
- ₹22 – ₹122.75
- One year
- −81.20%
- Return on equity (FY ending Mar 2026)
- -1.57%
Overview
- Symbol
- NSE:DHTL
- Sector
- Consumer Services
- Industry
- Consumer Discretionary
- Exchange
- NSE
- Currency
- INR
What Docmode Health Technologies Ltd does
Based on the company's own presentations, annual report and earnings calls.
DocMode operates a set of platforms for healthcare professionals (HCPs): DocMode LERN delivers certification programs, hybrid/blended CME courses, conferences and speaker events; DocMode SURE is a network of registered HCPs used for market research and real-world/post-marketing clinical studies; and DocMode CARE offers practice-enhancement tools including an AI-based Clinical Decision Support System and a clinical nutrition-management tool. DocMode KNOW provides medico-marketing content and CRM services to pharma and medical-marketing organizations, and DocMode SHOP (formerly STORE) is an online store selling books, journals, articles, event passes and memberships to HCPs. The company has also expanded into contract research, running a CDSCO-approved Ethics Committee and Contract Research Organization (CRO) offering Phase I-IV clinical trial management, post-marketing surveillance and Electronic Data Capturing (EDC) systems, plus CRAMS (Contract Research and Manufacturing Services) covering analytical testing, bioequivalence and stability studies for pharmaceutical R&D.
Segments
- DocMode LERN
- DocMode SURE
- DocMode CARE
- DocMode KNOW
- Clinical Research & CRO Services
- CRAMS Services
- DocMode SHOP
- Registered healthcare professionals — DocMode SURE platform
- 25,000
- Registered users — DocMode LERN platform
- 2,45,736
- Employees
- 75
- Business segments
- 7 (LERN, SURE, CARE, KNOW, CRO, CRAMS, SHOP)
- Information security certification
- ISO 27001:2013
- Clinical-trial regulatory approval
- CDSCO-approved Ethics Committee
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).
Financials
What the filings say
Net profit, year on year: +95% (quarter to mar 2026 against mar 2025).
| Line item | Mar 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 20 | 24 | 16 | 20 | 21 | 18 | 8 |
| Expenses | 19 | 21 | 17 | 21 | 22 | 17 | 9 |
| Operating profit | 1 | 3 | -1 | -0 | -1 | 1 | -1 |
| Operating margin | 7.2% | 11.5% | −5.1% | −0.6% | −2.7% | 4.5% | −15.0% |
| Other income | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 2 | -2 | -1 | -1 | -0 | -0 |
| Tax rate | 19.7% | 29.2% | −25.9% | 2.0% | 4.1% | 0.0% | 0.0% |
| Net profit | 1 | 1 | -1 | -1 | -2 | -0 | -0 |
| EPS (₹ per share) | 2.66 | 5.93 | -3.72 | -1.65 | -4.80 | -0.29 | -0.22 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 0 | 2 | 3 | 3 | 3 | 3 |
| Reserves | 1 | 1 | 7 | 5 | 5 | 5 |
| Borrowings | 5 | 8 | 9 | 7 | 7 | 4 |
| Other liabilities | 4 | 5 | 11 | 24 | 22 | 22 |
| Total liabilities | 10 | 17 | 30 | 39 | 38 | 34 |
| Fixed assets | 0 | 0 | 1 | 1 | 14 | 1 |
| Capital work in progress | 0 | 2 | 9 | 12 | 0 | 13 |
| Investments | 1 | 1 | 1 | 1 | 1 | 1 |
| Other assets | 8 | 14 | 19 | 25 | 23 | 18 |
| Total assets | 10 | 17 | 30 | 39 | 38 | 34 |
| Line item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Cash from operations | 0 | -0 | -2 | -1 | 4 | 7 |
| Cash from investing | -0 | -0 | -2 | -2 | -8 | -4 |
| Cash from financing | 0 | 1 | 3 | 3 | 6 | -4 |
| Net cash flow | -0 | 0 | -0 | 0 | 3 | -1 |
| Free cash flow | -0 | -1 | -2 | -2 | -3 | 3 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 70 | 112 | 92 | 105 | 81 | 107 |
| Inventory days | 669 | 589 | — | — | — | 822 |
| Days payable | 512 | 379 | — | — | — | 372 |
| Cash conversion cycle | 227 | 322 | 92 | 105 | 81 | 557 |
| Working capital days | 30 | 92 | 50 | 11 | -54 | -96 |
| Return on capital employed | 113.7% | 48.7% | 42.0% | 12.7% | −0.3% | 6.1% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Ownership
Who owns it
Public hold 70.50% as of Mar 2026.
- Promoters 29.50%
- Public 70.50%
Who bought this quarter
since Sep 2025
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- newly disclosed 1.41% held
- +1.09 pp 5.09% held
- newly disclosed 1.04% held
- +0.61 pp 3.82% held
The same filing shows 2 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Mar 2026 filing
Every holder of Docmode Health Technologies Ltd above SEBI's 1% disclosure line, and what changed since Sep 2025.
| Holder | Stake | Change |
|---|---|---|
| 16.58% | unchanged | |
| 16.37% | −1.41 pp | |
| 13.07% | unchanged | |
| 12.77% | unchanged | |
| 12.73% | unchanged | |
| 5.09% | +1.09 pp | |
| 3.82% | +0.61 pp | |
| 2.55% | −0.66 pp | |
| 1.41% | newly disclosed | |
| 1.27% | unchanged | |
| 1.04% | newly disclosed | |
| 0.06% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for Docmode Health Technologies Ltd
Free account: one company. Everything above stays public.
Write why you follow Docmode Health Technologies Ltd and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Consumer Services companies
- MT
MTEDUCAREMT Educare Limited - FE
FELFuture Enterprises Limited - UM
UMESLTDUsha Martin Education & Solutions Limited - CB
CBAZAARNet Avenue Technologies Ltd - DI
DILDebock Industries Ltd - ED
EDUCOMPEducomp Solutions Ltd - FE
FELDVRFuture Enterprises Limited - WI
WINNYWinny Immigration & Education Services Ltd
Learn to analyse Docmode Health Technologies Ltd
Guides on how to read this kind of business and the numbers that matter.